Welcome to our dedicated page for Innovative Indus SEC filings (Ticker: IIPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Innovative Industrial Properties, Inc. (IIPR) provide detailed insight into how the company describes its business as a real estate investment trust (REIT) focused on specialized industrial and life science real estate. Through Forms 8-K and other reports, the company discloses material events such as financial results, major investments, new credit facilities and changes in its capital structure.
In its current reports on Form 8-K, Innovative Industrial Properties outlines key transactions, including the Securities Purchase Agreement and related documents governing its preferred stock and revolving credit facility investments in IQHQ, Inc., a life science real estate platform. These filings summarize the terms of preferred stock, cumulative dividend rights, warrant coverage, redemption provisions and governance rights, as well as the structure and collateral of related loan agreements.
Other filings describe loan agreements and revolving credit facilities entered into by IIP Operating Partnership, LP and subsidiaries, including borrowing limits, borrowing base formulas, collateral packages and financial covenants such as liquidity and debt service coverage ratios. The company also files 8-Ks to furnish press releases that report quarterly financial results, rental revenues, net income attributable to common stockholders, AFFO, normalized FFO and dividend declarations.
On Stock Titan’s SEC filings page for IIPR, users can access these documents as they are made available through EDGAR, and use AI-powered summaries to understand complex provisions. Filings related to dividends, preferred stock terms, revolving credit facilities, tenant matters and strategic investments help investors analyze how Innovative Industrial Properties finances its portfolio, manages risk and pursues growth in cannabis-focused industrial properties and life science real estate.
Innovative Industrial Properties, Inc. subsidiary IIP Operating Partnership, LP entered into a Loan Agreement dated October 3, 2025 that provides a secured revolving credit facility with availability up to $100,000,000 and a maturity date of October 3, 2028. The facility includes a $35,000,000 accordion feature that can expand total capacity to $135,000,000 if lenders increase commitments.
Availability under the facility is subject to a borrowing base based on eligible investments and a receivable, and obligations are secured by substantial loan-party assets, including a revolving credit note from IQHQ, LP, Series G-1 cumulative redeemable preferred stock of IQHQ, Inc., and a corresponding warrant for common equity units of IQHQ Holdings, LP. The agreement requires a Debt Service Coverage Ratio of not less than 2.0 to 1.0, measured at each fiscal quarter end.
Innovative Industrial Properties, Inc. completed the initial closing of a previously announced preferred equity investment in IQHQ REIT on September 30, 2025 through its subsidiary IIP Life Science Investments LLC. The subsidiary purchased Series G-1 Preferred Stock at $1,000 per share for a total investment of approximately $5.0 million and received a warrant exercisable for common equity units equal to 1.5% of fully diluted IQHQ Holdings, LP. On the same date, IIP Life Science funded a committed loan of $100.0 million to IQHQ OP, bringing total funded amounts under the related reserve credit facility to $400.0 million. The Company also obtained a contractual right of first offer on certain IQHQ real estate assets. The report lists related agreements and a press release as exhibits and is signed by CFO David Smith.
Innovative Industrial Properties, through its operating partnership IIP OP, agreed to a multi-part strategic investment in IQHQ entities consisting of up to $170.0 million to purchase cumulative redeemable preferred stock and a $100.0 million committed lender role in a revolving credit facility. The preferred shares carry a 10.0% cash dividend and an initial 5.0% PIK dividend, with PIK step-ups and certain penalty mechanics tied to Trigger Events.
The transaction includes equity warrants (initial 1.5% and subsequent 3.5% coverage at $0.01 exercise price), a contractual right of first offer on IQHQ real estate sales, the right to appoint a voting director (intended to be CEO Paul Smithers), and customary closing conditions, timing limits and default/penalty provisions.
IIPR’s Q2-25 results show weakening fundamentals amid tenant stress. Rental revenue fell 21% YoY to $62.9 m as PharmaCann and other operators struggled, driving net income down 38% to $26.0 m and diluted EPS to $0.86 (vs $1.44).
Cash flow from operations remained positive at $102.7 m but slipped 24% YoY; cash on hand dropped to $99.7 m after funding $22.9 m of investments, repurchasing $20.1 m of common stock and paying $108.7 m in common dividends ($1.90/sh each quarter). Dividends now exceed cumulative earnings, pushing “dividends in excess of earnings” to –$264 m.
Balance-sheet leverage is modest (liabilities $425 m vs equity $1.88 b), yet the $291 m 5.5% notes maturing May 2026 loom large. Management admits current liquidity is insufficient and intends to refinance, assuming access to capital markets.
Tenant concentration remains high: top five operators generated 49% of rental revenue; PharmaCann defaulted in March, nullifying rent concessions, while two leases shifted to sales-type accounting with cash payments booked as deposits. An impairment of $3.5 m was recorded in Q1 and one California asset was sold for $1.8 m at book value.
The company issued 559 k Series A preferred shares via its ATM for $13.2 m and increased preferred outstanding to 1.56 m shares; early bond repayments of $8.8 m trimmed debt. Multiple securities-law class actions remain pending.